Crinetics Pharmaceuticals CRNX Accrued Expenses
Accrued Expenses at other companies
Other financials
Where this comes from
Reported directly by Crinetics Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OtherAccruedLiabilitiesCurrent.
The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Crinetics Pharmaceuticals's accrued expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Crinetics Pharmaceuticals's accrued expenses?
- Crinetics Pharmaceuticals (CRNX) reported accrued expenses of $3.11M in Q1 2026.
- What is the long-term trend for Crinetics Pharmaceuticals's accrued expenses?
- Over 4 years (2020 to 2025), Crinetics Pharmaceuticals's accrued expenses has grown at a 36.0% compound annual growth rate (CAGR), from $835K to $2.85M.
- What does accrued expenses mean?
- Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.